논문정보 : Heo JH, Suh DC, Kim S, Lee EK. Evaluation of the pilot program on the real-time drug utilization review system in South Korea. Int J Med Inform. 2013;82(10):987-95.
논문정보 : Han E, Kim TH, Jeung MJ, Lee EK. Analyses of direct and indirect impacts of a positive list system on pharmaceutical R&D investments. Clin Ther. 2013;35(7):941-9.
논문정보 : Cho SK, Sung YK, Choi CB, Kwon JM, Lee EK, Bae SC. Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database. Rheumatol Int. 2013;33(12):2985-92.
논문보기 : 10.1007/s00296-013-2833-x
논문정보 : Park MH, Jo C, Bae EY, Lee EK. A comparison of preferences of targeted therapy for metastatic renal cell carcinoma between the patient group and health care professional group in South Korea. Value Health. 2012;15(6):933-9.
논문보기 : 10.1016/j.jval.2012.05.008
논문정보 : Lee EK, Revil C, Ngoh CA, Lister J, Kwon JM, Park MH, et al. Clinical and cost effectiveness of bevacizumab + FOLFIRI combination versus FOLFIRI alone as first-line treatment of metastatic colorectal cancer in South Korea. Clin Ther. 2012;34(6):1408-19.
논문정보 : Lee EK, Kim BY, Lim JY, Park MH. Different policy outcomes of the new drugs and currently listed drugs under the positive list system in South Korea. Value Health. 2012;15(1 Suppl):S100-3.
논문보기 : 10.1016/j.jval.2011.11.017
논문정보 : Kwon JM, Cho SK, Kim JH, Lee EK. Medical costs for Korean patients with rheumatoid arthritis based on the national claims database. Rheumatol Int. 2012;32(9):2893-9.
논문보기 : 10.1007/s00296-011-2117-2